ReviewJournal of hematology & oncology2026
Evolving antibody-drug conjugates in breast cancer from precision delivery to tumor microenvironment reprogramming.
Na Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it